Atopic dermatitis patients on Janus kinase inhibitors have increased risk of infection compared to biologics: Study Jacinthlyn Sylvia16 April 2025 9:00 PM ISTA new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on biologics, the patients...
Medical Bulletin 03/November/2023 Isra Zaman3 Nov 2023 3:15 PM ISTHere are the top medical news of the day:JAK inhibitors show promising efficacy in rheumatoid arthritis treatmentA retrospective multicenter study...
JAK inhibitors show promising efficacy in rheumatoid arthritis treatment Isra Zaman3 Nov 2023 9:30 AM ISTA retrospective multicenter study conducted by Japanese researchers has found that Janus kinase (JAK) inhibitors, a class of drugs used to treat...
JAK inhibitors promising for treatment of psoriasis and psoriatic arthritis Jacinthlyn Sylvia5 Oct 2022 8:00 PM ISTCanada: The treatment of moderate-to-severe psoriasis and psoriatic arthritis (PsA) with Janus Kinase (JAK) inhibitors is safe and appears promising,...
No risk of VTE in Eczema Patients Receiving JAK Inhibitors: Study Dr. Shravani Dali17 Sept 2022 10:00 AM ISTThere is no risk for venous thromboembolism in Eczema Patients Receiving JAK Inhibitors suggests a new study published in the JAMA Dermatology. ...
Tofacitinib Does not Raise risk of VTE in Rheumatoid Arthritis Patients: Study MD Bureau5 April 2021 2:00 PM ISTVenous thromboembolism (VTE), which includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is a common medical problem with an annual...
